VITR — Vitrolife AB Cashflow Statement
0.000.00%
- SEK12.30bn
- SEK13.09bn
- SEK3.44bn
Annual cashflow statement for Vitrolife AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 460 | 537 | -3,712 | 674 | -4,886 |
| Depreciation | |||||
| Non-Cash Items | -30.8 | 80 | 4,376 | 67 | 5,860 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -154 | -377 | -332 | -276 | -339 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 384 | 636 | 757 | 907 | 635 |
| Capital Expenditures | -62.4 | -87 | -119 | -202 | -270 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -6,456 | -57 | -5 | -175 | -32 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6,518 | -144 | -124 | -377 | -302 |
| Financing Cash Flow Items | -33.4 | -12 | -1 | -1 | -10 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5,749 | -582 | -300 | -286 | -553 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -343 | -51 | 283 | 273 | -326 |